Clinical IntelligenceReedley Review

A medication review, assembled before you start.

Medicines, indications, results, allergies, letters and monitoring are gathered into one structured brief with sources; you edit it, write the review and record it as yours.

Illustrative demonstration · intended workflow

Interactive demonstration

Synthetic patient · pause, step and replay at any point

Reedley Review

Synthetic patient

A structured medication review prepared from the synthetic record, each line with its source. The medication review brief is not in the development build. Copy-out only; nothing is written to any record.

Daniel OKONKWONHS 999 000 0115Born 02 Nov 1961 · 65 y · maleRecord as of 12 Nov 2026 10:30
Daniel OKONKWO NHS 999 000 0115

Born 02 Nov 1961 · 65 y · male · Record as of 12 Nov 2026 10:30

A structured medication review prepared from the synthetic record, each line with its source. The medication review brief is not in the development build. Copy-out only; nothing is written to any record.

Step 1 of 10 · Review opened

  1. Review opened
  2. Medicines gathered
  3. Investigations and allergies
  4. Medication history read
  5. Correspondence read
  6. Monitoring rules read
  7. Review brief assembled
  8. Items to verify
  9. Follow-up questions
  10. Note edited and attested
Prepare medication review

Structured medication review · appointment 12 Nov 2026 10:30 · previous review 14 Nov 2025

K. AHMED, clinical pharmacist (prescriber)

Reedley work history · 2 Nov 2026 08:15Consultation · 14 Nov 2025 · K. AHMED
  1. Medicines gathered and comparedFound · 2 sourcesCurrent medication record: found; Problem list: found

    Current medication record · 5 / Problem list · 4

    4 current medicines · 1 without a recorded indication

  2. Investigations and allergiesFound · 2 sourcesResults: found; Allergies and intolerances: found

    Results · 7 / Allergies and intolerances · 1

    7 results, shown as reported · 1 intolerance

  3. Medication historyFound · 2 sourcesMedication history: found; Consultations: found

    Medication history · 8 / Consultations · 8

    3 changes since the last review on 14 Nov 2025

  4. Specialist correspondenceFound · 2 sourcesLetter paragraphs (3 letters): found; Referrals: found

    Letter paragraphs (3 letters) · 11 / Referrals · 2

    3 letters · 1 difference to verify · 1 with a later reply in correspondence

  5. Monitoring requirementsFound · 2 sourcesPractice monitoring rules (draft · unsigned): found; Reedley work history: found

    Practice monitoring rules (draft · unsigned) · 16 / Reedley work history · 16

    2 medicines with a draft-rule requirement · next U&E due by 9 Nov 2027

Preparation finished · nothing has been reviewed yet

Current medicines and indications

From: Medicines gathered and compared

Allergies and intolerances

From: Investigations and allergies

Recent investigations, as reported

From: Investigations and allergies

Values as the laboratory reported them. Reedley does not interpret results.

Changes since the last review

From: Medication history

Specialist correspondence

From: Specialist correspondence

Monitoring requirements · draft rules

From: Monitoring requirements

Practice draft rules · draft · unsigned · no named clinical owner yet. The draft rules do not yet take account of kidney function category, age or indication; a clinician sets each patient’s interval.

Open work

From: Monitoring requirements

Documented points for the conversation

From: Monitoring requirements

Drawn only from documented facts. Reedley does not suggest changes to treatment.

Items to verify

From: Monitoring requirements

Differences between sources and gaps in the record, with the evidence for each. Each starts as not reviewed; only the clinician can mark one reviewed.

4 items to verify · none reviewed yet

  1. Sources differ

    Renal letter and medication record differ on amlodipine

    The renal clinic letter dated 5 Oct asks for an amlodipine increase and lists amlodipine 5 mg in the clinic’s medication list. The record shows amlodipine stopped on 17 Jun 2026. The reply dated 20 Oct refers to lercanidipine instead.

    1 with a later reply in correspondence

    Renal clinic letter ¶1 · dated 5 Oct 2026Medication record · 17 Jun 2026Renal clinic reply ¶1 · dated 20 Oct 2026
    Not reviewedReviewed by K. AHMED · 10:52
  2. Not found in the available record

    No indication on the dapagliflozin entry

    The medication entry has no indication text. The renal clinic letter gives the reason for starting it.

    medication record · as at 12 Nov 2026Renal clinic letter ¶3 · dated 5 Oct 2026
    Not reviewedReviewed by K. AHMED · 10:53
  3. Not found in the available record

    No blood pressure recorded since 15 Jul 2026

    The latest recorded blood pressure is 134/82 on 15 Jul 2026. A recheck is booked for 16 Nov; booked is not attended.

    Consultation · 15 Jul 2026 · Practice nurseReedley work history · 29 Oct 2026 14:06
    Not reviewedReviewed by K. AHMED · 10:54
  4. Not found in the available record

    No entry about palpitations since 4 Sep 2026

    The cardiology letter’s bisoprolol sentence is conditional. The 4 Sep telephone note records his preference; no later entry mentions palpitations.

    Cardiology clinic letter ¶4 · dated 2 Sep 2026Consultation · 4 Sep 2026 · Dr S. PATEL
    Not reviewedReviewed by K. AHMED · 10:55

Follow-up questions

Has he previously been prescribed amlodipine?

Context kept: Patient: Daniel OKONKWO · this review

Yes. Amlodipine 5 mg once daily from 16 May 2022, increased to 10 mg on 22 Apr 2026, stopped on 17 Jun 2026.

Medication record · 16 May 2022Medication record · 22 Apr 2026Medication record · 17 Jun 2026

What was documented about the reason for stopping it?

Context kept: “it” = amlodipine, from the previous answer

The medication record gives the reason as ankle oedema. The consultation on 17 Jun 2026 (Dr S. PATEL) records six weeks of ankle swelling since the April increase.

Medication record · 17 Jun 2026Consultation · 17 Jun 2026 · Dr S. PATEL

Add the relevant history to my review notes.

Context kept: “the relevant history” = the amlodipine entries from the two previous answers

Added one line to the draft note, highlighted. Edit or remove it before copying.

Medication record · 16 May 2022Medication record · 17 Jun 2026Medication record · 17 Jun 2026
Draft review note · editableDraft · not reviewed

Copy-out only; nothing is written to any record. Copied text starts “DRAFT · SYNTHETIC DEMONSTRATION · NOT FOR CLINICAL USE”.

Clinician attestation

I have reviewed this brief and edited the draft note.

4 items to verify · none reviewed yet

Recorded only when the clinician chooses to attest.

Attestation recorded · K. AHMED, clinical pharmacist (prescriber) · 12 Nov 2026 10:58

An attestation records who reviewed the brief and when. It does not verify anything and does not change a lifecycle state.

Structured medication reviewAssignedStill open: closes only when a medication review entry is read from the clinical record (Simulated).

Sources behind the brief · 36 entries and draft rules, each cited passage marked

Sources behind the brief

36 entries and draft rules, newest first · as of 12 Nov 2026 10:30

08:31 · Reedley, from the clinical record (Simulated)

Reviewed and filed by K. AHMED 12 Nov 2026 08:31. U&E item closed · completed.

Medication record · as at 12 Nov 2026

Lercanidipine 10mg tablets 10 mg once daily · indication: hypertension · last issued 2 Nov 2026

Medication record · as at 12 Nov 2026

Ramipril 10mg capsules 10 mg once daily · indication: hypertension · last issued 2 Nov 2026

Medication record · as at 12 Nov 2026

Atorvastatin 20mg tablets 20 mg at night · indication: hypercholesterolaemia · last issued 2 Nov 2026

Medication record · as at 12 Nov 2026

Dapagliflozin 10mg tablets 10 mg once daily · no indication recorded · last issued 2 Nov 2026

Northfield Pathology (fictional) · received 9 Nov 2026 15:20

U&E: Na 140 mmol/L, K 4.6 mmol/L, creatinine 131 µmol/L, eGFR 52 mL/min/1.73m² · no laboratory flag

08:15 · K. AHMED

Assigned: structured medication review · owner K. AHMED · appointment 12 Nov 10:30 (medication review date on the repeat template: 14 Nov 2026).

14:06 · Reedley (Simulated)

Booked by the patient for 16 Nov 09:20 · attendance not yet confirmed.

Dr A. FENWICK · Northfield General Hospital (fictional)

Thank you for your query of 6 October. My letter of 5 October was written from an out-of-date medication list and should have referred to lercanidipine. Please continue lercanidipine 10 mg once daily; I am not asking for any change to it.

Dr A. FENWICK · Northfield General Hospital (fictional)

I would still be grateful if his blood pressure could be rechecked in 4 weeks, as planned.

K. AHMED

Dapagliflozin 10 mg once daily started. No indication text entered.

K. AHMED

Telephone: renal clinic letter of 5 Oct discussed. Dapagliflozin 10 mg once daily started as requested in the letter; sick-day guidance explained. Amlodipine instruction queried with the renal team because he no longer takes amlodipine.

Dr A. FENWICK · Northfield General Hospital (fictional)

Please increase amlodipine to 10 mg once daily and recheck blood pressure in 4 weeks.

Dr A. FENWICK · Northfield General Hospital (fictional)

His urine albumin:creatinine ratio remains raised. I would be grateful if you could start dapagliflozin 10 mg once daily for his chronic kidney disease and check his urea and electrolytes 4 to 6 weeks after starting.

Dr A. FENWICK · Northfield General Hospital (fictional)

I will review him in the renal clinic in 6 months.

Dr A. FENWICK · Northfield General Hospital (fictional)

Seen in the renal clinic on 29 September 2026. Medication list as provided at clinic: amlodipine 5 mg once daily, ramipril 10 mg once daily, atorvastatin 20 mg at night.

Dr S. PATEL

Telephone: cardiology letter discussed. Palpitations now infrequent. Prefers not to start a new medicine at present; will contact the practice if they become troublesome.

Dr J. MORLEY · Northfield General Hospital (fictional)

I would recommend continuing his current antihypertensive treatment, aiming for a clinic blood pressure below 140/90 mmHg.

Dr J. MORLEY · Northfield General Hospital (fictional)

If the palpitations become troublesome, please consider bisoprolol 1.25 mg once daily.

Dr J. MORLEY · Northfield General Hospital (fictional)

I have not arranged further cardiology follow-up and have discharged him to the care of his GP.

Practice nurse

BP check. Ankle swelling resolved since stopping amlodipine. BP 134/82. Continue lercanidipine.

Synthetic Practice

12-lead ECG: sinus rhythm, rate 72 per minute (practice-recorded report)

Dr S. PATEL

Amlodipine stopped. Reason recorded: ankle oedema.

Dr S. PATEL

Lercanidipine 10 mg once daily started. Indication: hypertension.

Dr S. PATEL

Ankle swelling both legs for 6 weeks since amlodipine increased to 10 mg in April. No breathlessness. Mild pitting oedema to mid-shin. BP 138/84. Amlodipine stopped because of ankle oedema; switched to lercanidipine 10 mg OD. Review in 4 weeks.

Northfield Pathology (fictional) · received 3 Jun 2026 15:48

U&E: Na 140 mmol/L, K 4.7 mmol/L, creatinine 124 µmol/L, eGFR 56 mL/min/1.73m² · no laboratory flag

Northfield Pathology (fictional) · received 3 Jun 2026 15:48

Urine albumin:creatinine ratio 38 mg/mmol · flagged H by the laboratory

Dr S. PATEL

Amlodipine increased from 5 mg to 10 mg once daily.

K. AHMED

Structured medication review. Taking amlodipine 5 mg, ramipril 10 mg and atorvastatin 20 mg as prescribed. Home BP average 146/88. No side effects reported. Next medication review 14 Nov 2026.

Northfield Pathology (fictional) · received 14 Nov 2025 16:05

Lipid profile: total cholesterol 4.1 mmol/L, LDL cholesterol 2.0 mmol/L · no laboratory flag

Amlodipine 5 mg once daily started. Indication: hypertension.

Atorvastatin 20 mg at night started. Indication: hypercholesterolaemia.

Codeine — nausea and vomiting (intolerance)

U&E at least every 12 months while on an ACE inhibitor or angiotensin receptor blocker.

U&E at least every 12 months while on dapagliflozin; an earlier test requested in specialist correspondence is followed as written.

ALT within 3 months and at 12 months after starting a statin.

Illustrative demonstration · intended workflow · Scripted reconstruction: the development build itself is not running on this page.

  • Each medicine shown with its indication, recent changes and monitoring.
  • Open items come from the record: overdue tests, unactioned letter instructions.
  • The clinician edits the brief and records the review in their name.

From what arrives to what you decide

  1. What entersMedicines, indications, results, allergies, letters and monitoring
  2. What Reedley preparesOne structured brief, every line with its source
  3. What the clinician decidesYou edit the brief, write the review and record it as yours

What it does not do · what exists today

  • The brief contains no prescribing suggestions.
  • No interaction or dose checking is performed.
  • The review brief is an illustration of intended workflow. It builds on Patient Context, which is in the development build.
  • Not yet in Reedley’s intended-purpose register: shown to explore the workflow, not as committed product scope.

Every patient shown is synthetic. No integration with a clinical system is claimed, and no clinician has yet used Reedley in practice. Safety and governance

See it with your own work in mind.

Tell us your role and the workflows you care about, and we will walk you through them on synthetic data.